logo
Share SHARE
FONT-SIZE Plus   Neg

LCH.Clearnet Confirms Talks With NYSE Euronext On European Clearing Strategy

Responding to NYSE Euronext's (NYX) announcement regarding its European clearing strategy, LCH.Clearnet Group Limited, a counterparty clearing house in Europe, on Wednesday confirmed that it has held constructive preliminary discussions with NYSE Euronext. The talks were regarding its current intentions with respect to the clearing arrangements of its cash equities and derivatives businesses.

In its statement, LCH.Clearnet welcomed NYSE Euronext's intention to agree a long term clearing arrangement with the clearing house with respect to its continental regulated cash equities markets. This would replace the existing contract with a new long term arrangement. For the existing contract, a termination notice had initially been served in May 2010, and the contract extended until December 2013.

Ian Axe, CEO of LCH.Clearnet said, "LCH.Clearnet will work collaboratively with NYSE Euronext, clients, market participants and regulators to ensure a smooth transition and continuation of clearing services. We wish NYSE Euronext every success in its clearing strategy and look forward to continuing to serve NYSE Euronext as a key long term client and clearing member in cash equities."

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
The holiday throng seeking to take a flight out to their preferred destinations at the at New York's Kennedy International Airport ahead of the Memorial Day holiday were in for a rude shock. Technology played a spoilsport, as a computer system broke down Sunday evening at a terminal, causing flight delays and cancellations that resulted in manual check-in process for thousands of holiday passeng The month of May saw the FDA greenlight 5 new drugs, including 1 new molecular entity, and surprisingly turn down 1 drug candidate, whose approval was considered a no-brainer by some experts. Lab equipment maker Thermo Fisher Scientific Inc. has agreed to acquire electron microscope maker FEI Co. for about $4.2 billion in cash, the two companies said Friday. Thermo Fisher noted that FEI's electron microscopy platform will complement its own mass spectrometry systems to accelerate advancements in structural biology.
comments powered by Disqus
Follow RTT